Betnovate (-g/100g cream)
$7.47
Betnovate is a topical cream that contains the active ingredient betamethasone, a potent corticosteroid. It is commonly prescribed by healthcare professionals to treat various skin conditions such as eczema, psoriasis, and dermatitis. The cream helps to reduce inflammation, redness, itching, and swelling associated with these skin conditions. It is typically applied directly to the affected area in a thin layer, and the frequency of application may vary depending on the severity of the condition and the doctor’s instructions. Betnovate should be used as directed and for the prescribed duration, as prolonged use or overuse may lead to side effects. It is important to consult a healthcare professional before using Betnovate or any other medication to ensure its suitability for your specific condition.
Betnovate is a topical medication available in the form of a cream containing betamethasone valerate, a synthetic corticosteroid. It is primarily used to treat various inflammatory skin conditions, such as eczema, psoriasis, dermatitis, and allergic reactions.
The active ingredient in Betnovate, betamethasone valerate, works by reducing inflammation, itching, and redness associated with these skin conditions. It is a potent corticosteroid that helps to suppress the immune response and alleviate symptoms.
Usage Information: Before applying Betnovate cream, it is important to clean and dry the affected area thoroughly. A thin layer of the cream should be gently and evenly applied to the affected skin, usually once or twice daily as directed by a healthcare professional. It is important to follow the prescribed dosage and duration of treatment. In some cases, the cream may be covered with a dressing or bandage if instructed by a doctor.
It is essential to avoid using Betnovate cream on the face, groin, or underarms unless specifically instructed by a healthcare professional, as prolonged use on these areas may lead to skin thinning and other side effects. The cream should not be applied to broken skin or areas with active infection, and contact with the eyes should be avoided.
Side Effects: While Betnovate cream is generally well-tolerated, it may cause some side effects, especially if used for prolonged periods or in excessive amounts. Common side effects may include:
- Skin irritation, itching, or burning at the application site
- Dry or thinning skin
- Skin discoloration
- Stretch marks
- Acne or worsening of existing acne
- Increased hair growth
- Allergic reactions (rare but possible)
It is important to note that prolonged or excessive use of Betnovate cream can lead to systemic absorption of the corticosteroid, which may increase the risk of systemic side effects, such as adrenal suppression, Cushing’s syndrome, or reduced immune response.
It is advisable to use Betnovate cream as directed and for the prescribed duration. If any severe or persistent side effects occur, or if the condition worsens, it is recommended to consult a healthcare professional for further evaluation and guidance.
| Weight | 0.06 kg |
|---|---|
| Dimensions | 3 × 3 × 1 cm |
Related products
Betnovate (1mg/g ointment) is a topical medication used to treat various skin conditions. It contains the active ingredient betamethasone valerate, a potent corticosteroid that helps reduce inflammation, itching, and redness associated with skin problems. The ointment is typically applied to the affected area once or twice daily, as directed by a healthcare professional. Betnovate can be effective in treating conditions such as eczema, psoriasis, dermatitis, and other inflammatory skin conditions. However, it is important to follow the instructions and precautions provided by a healthcare provider when using this medication.
Tremfya (100mg Pfs) is a medication used to treat certain skin conditions, particularly moderate to severe plaque psoriasis. It contains the active ingredient guselkumab, which is a monoclonal antibody that works by targeting a specific protein in the body's immune system. This protein, called interleukin-23 (IL-23), plays a key role in the development of psoriasis. By blocking IL-23, Tremfya helps reduce the inflammation and symptoms associated with this chronic skin condition. The medication is administered through subcutaneous injections, typically once every few weeks, and it has been shown to provide significant improvement in the skin condition for many patients. It is important to note that Tremfya is available only with a prescription and should be used under the guidance of a healthcare professional.